DHL Invests in Logistics Infrastructure for Life Science Industry in Asia
- Posted on 07 October 2009
DHL is investing US$15 million in three life science competence centers to fulfill growing demand for higher levels of quality compliance. Located in Singapore, Mumbai, and Hyderabad, the centers will bolster the company’s logistics capabilities for the life science industry in the region.
In 2009, the global pharmaceuticals sector, a key segment of the life science industry, is estimated to be worth US$820 billion, with an expected growth rate of 14-15 percent in emerging markets.
The life science competence centers in Asia will comprise a core team of industry professionals who will develop solutions for customers to better manage their international supply chains.
The life science industry in India has seen stricter regulatory requirements for quality compliance. The competence centers fill the gap in the existing supply chain, by providing improved temperature controlled handling and storage, greater product transparency and visibility, and complete end-to-end logistics capabilities.
Many healthcare companies have set up their regional headquarters and distribution centers in Singapore. Pharmaceutical exports are expected to grow to US$5.95 billion by 2013.
It is also a key transportation hub receiving pharmaceutical products inbound from major manufacturing sources, and providing storage and onward distribution service to Asia, the US and Europe.
